The House Energy and Commerce Committee seems poised to make substantial changes to the Food and Drug Administration’s (“FDA’s”)...
This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Reed Smith LLP
Updates by Reed Smith on U.S. legislative & regulatory developments affecting the health care industry